Business Context and Reporting Period
Company: James Hardie Industries plc
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Date: September 25, 2018
Principal Executive Offices: Dublin, Ireland
This filing serves as a notification of a substantial shareholding and includes standard forward-looking statement disclosures. It does not contain a full set of financial results for a specific quarter or year.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural filing referencing exhibits regarding shareholding notifications rather than a financial results report.
Material Changes
No material financial changes versus prior periods are detailed in this text. The filing references a "Substantial Shareholding Notification" (Exhibit 99.1) and "Appendix 3Y" (Exhibit 99.2), indicating a change in ownership structure or regulatory reporting requirements, but specific details of these changes are not included in the provided text.
Guidance, Outlook, and Risks
Forward-Looking Statements: The document contains an extensive disclaimer regarding forward-looking statements. These include projections on future performance, capital expenditure, credit facilities, dividends, and share buy-backs.
Key Risks Identified:
- Asbestos Liability: Risks related to prior asbestos manufacturing, including contributions to the Asbestos Injuries Compensation Fund (AICF), potential shortfalls, and currency exchange impacts on liabilities.
- Legal and Regulatory: Exposure to product liability, environmental, and consumer class action proceedings.
- Market Conditions: Dependence on US and Asia Pacific housing markets, new home construction levels, and consumer confidence.
- Operational: Supply and cost of raw materials, competition, and integration of the Fermacell business.
- Financial: Currency exchange risks and the ability to renew credit facilities on favorable terms.
Investor Verification Checklist
- Review Exhibit 99.1 (Substantial Shareholding Notification) to identify the specific investor and the magnitude of the shareholding change.
- Consult the most recent Form 20-F or quarterly earnings release for actual revenue, profit, and cash flow figures, as they are absent here.
- Verify the current status of the Asbestos Injuries Compensation Fund (AICF) and any recent updates to asbestos liability estimates.
- Check for updates on the Fermacell integration progress and associated capital expenditure plans.
- Monitor currency exchange rates (USD/AUD/EUR) given the company's international exposure and the specific risk noted regarding asbestos liabilities.